Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections

Area of Science:

• Parasitology
• Biochemistry
• Immunology

Background:

• Matrix metalloproteinases (MMPs) are crucial for tissue remodeling and are implicated in protozoan parasite infections.
• Imbalances between MMPs and their inhibitors are observed in malaria, trypanosomiasis, leishmaniasis, and toxoplasmosis, leading to excessive proteolysis.

Purpose of the Study:

• To review the current research on matrix metalloproteinases (MMPs) in major protozoan parasitic diseases.
• To explore the role of MMPs in parasite-induced immunopathology and tissue damage, particularly blood-brain barrier integrity.
• To identify potential therapeutic strategies targeting MMPs in these infections.

Main Methods:

• Literature review of studies on MMPs in malaria, trypanosomiasis, leishmaniasis, and toxoplasmosis.
• Analysis of mechanisms underlying MMP dysregulation by parasite products and host immune responses.
• Examination of the impact of MMPs on disease pathologies, including cerebral malaria and encephalitis.

Main Results:

• Protozoan parasitic infections consistently disrupt the MMP/inhibitor balance, promoting proteolytic activity.
• Leukocyte influx and parasite products, like hemozoin, contribute to MMP-mediated tissue damage and blood-brain barrier disruption.
• Parasites themselves can produce metalloproteinases, adding complexity to disease pathogenesis.

Conclusions:

• MMP dysregulation is a common feature across major protozoan parasitic infections, contributing to significant immunopathology.
• Targeting MMPs with inhibitors presents a promising therapeutic avenue to mitigate tissue damage and improve outcomes in parasitic diseases.
• Further research is needed to elucidate parasite-specific mechanisms influencing host MMP expression and activity.